Trials / Terminated
TerminatedNCT04889989
Microwave Ablation in Chinese Patients With Lung Tumors
A Single-Arm, Prospective, Multicenter Study to Evaluate the Effectiveness and Safety of the NeuWave Certus Microwave Ablation System in Chinese Patients With Primary or Secondary Tumors in the Lung
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Ethicon, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Adult patients with non-small cell lung cancer (NSCLC) or oligometastatic lung tumors will all receive microwave ablation (MWA) performed percutaneously by doctors who are experienced in lung tumor ablation. 120 patients will participate across 8 clinical study sites all in China.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Microwave Ablation | Percutaneous microwave ablation using the NeuWave Microwave Ablation System for non-small cell lung cancer or oligometastatic lung tumors |
Timeline
- Start date
- 2021-12-27
- Primary completion
- 2022-10-22
- Completion
- 2023-09-14
- First posted
- 2021-05-18
- Last updated
- 2026-02-04
- Results posted
- 2024-10-15
Locations
8 sites across 1 country: China
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04889989. Inclusion in this directory is not an endorsement.